iShares Global Healthcare ETF vs State Street SPDR Biotech ETF. Which Healthcare-Focused Fund Will Bring You Profits in 2026 and Beyond?
Motley Fool · 2026-08-08
TOPIC
Biotech & FDA News
FDA drug approvals, clinical trial results, and biotech stock-moving news.
Related Tickers
$LLY · Eli Lilly$NVO · Novo Nordisk$JNJ · Johnson & Johnson$PFE · Pfizer$MRK · Merck$ABBV · AbbVie$UNH · UnitedHealthLatest Coverage
EyePoint: Phase 3 Design Creates A More Valuable Durability Story
Seeking Alpha · 2026-08-08
Global pharma giants turn to Chinese biotech to tap innovation, valuation growth
SCMP Business · 2026-08-08
Collegium Pharmaceutical, Inc. Q2 2026 Earnings Call Summary
Moby · 2026-08-08
Ligand Pharmaceuticals Incorporated Q2 2026 Earnings Call Summary
Moby · 2026-08-08
ANI Pharmaceuticals, Inc. 2026 Q2 - Results - Earnings Call Presentation
Seeking Alpha · 2026-08-08
Emcure Pharmaceuticals Ltd (BOM:544210) (Q1 2027) Earnings Call Highlights: Revenue Surges 22. ... - Yahoo! Finance Canada
Yahoo! Finance Canada · 2026-08-08
MRNA Stock Gets a Shot in the Arm as FDA Approves Moderna Flu Vaccine
Barchart · 2026-08-08
U.S. IPO Weekly Recap: August Kicks Off With Flurry Of Biotech IPOs
Seeking Alpha · 2026-08-08
Wasted medicine in England could fill 75 swimming pools a year, pharmacy group says
Guardian Business · 2026-08-07
Supernus Pharmaceuticals, Inc. (SUPN) Indivior Pharmaceuticals, Inc., - M&A Call - Slideshow
Seeking Alpha · 2026-08-07
US FDA to hold advisory meeting to review Grail's multi-cancer test - Reuters
Reuters · 2026-08-07
HQH: After Biotech's Breakout Year, This Healthcare CEF Still Trades Below NAV; Buy
Seeking Alpha · 2026-08-07
Replimune Wins FDA Skin Cancer Drug Approval on Third Try. Why the Stock Is Tumbling. - Barron's
Barron's · 2026-08-07
ANI Pharmaceuticals, Inc. (ANIP) Q2 2026 Earnings Call Transcript
Seeking Alpha · 2026-08-07
Vanda Pharmaceuticals Inc. Q2 2026 Earnings Call Summary
Moby · 2026-08-07
BioMarin Pharmaceutical Inc. 2026 Q2 - Results - Earnings Call Presentation
Seeking Alpha · 2026-08-07
Is the biotech capital of the world moving? - STAT
STAT · 2026-08-07
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BI Markets · 2026-08-07
As US-China pharma rivalry heats up, can Hong Kong’s US$8b fund be the global bridge?
SCMP Business · 2026-08-07
Kalshi and Polymarket bets on clinical trials criticized as 'ghastly' - npr.org
npr.org · 2026-08-07
Earnings call transcript: Nxera Pharma posts stronger H1 2026 profit, shares slip
Investing.com · 2026-08-07
Earnings call transcript: EQL Pharma flags weak Q1 2026 as recovery hopes build
Investing.com · 2026-08-07
Collegium Pharmaceutical, Inc. 2026 Q2 - Results - Earnings Call Presentation
Seeking Alpha · 2026-08-07
BioCryst Pharmaceuticals, Inc. Q2 2026 Earnings Call Summary
Moby · 2026-08-07
Corvus Pharmaceuticals, Inc. (CRVS) Q2 2026 Earnings Call Transcript
Seeking Alpha · 2026-08-07
Verrica Pharmaceuticals earnings missed by $0.08, revenue topped estimates
Investing.com · 2026-08-07
Xenon Pharmaceuticals Inc. (XENE) Q2 2026 Earnings Call Transcript
Seeking Alpha · 2026-08-07
Amphastar Pharmaceuticals, Inc. (AMPH) Q2 2026 Earnings Call Transcript
Seeking Alpha · 2026-08-07
Rigel Pharmaceuticals, Inc. Q2 2026 Earnings Call Summary
Moby · 2026-08-07
BioMarin Pharmaceutical Inc. (BMRN) Q2 2026 Earnings Call Transcript
Seeking Alpha · 2026-08-06
Earnings call transcript: Guardian Pharmacy lifts 2026 outlook on Q2 margin gains
Investing.com · 2026-08-06
Earnings call transcript: Puma Biotechnology tops Q2 2026 estimates as profit returns
Investing.com · 2026-08-06
After two rejections and mass layoffs, Replimune melanoma drug wins FDA approval - The Business Journals
The Business Journals · 2026-08-06
FDA grants fast track status to Aclaris’ lichen planus drug
Investing.com · 2026-08-06
FDA Approves Replimune’s Melanoma Drug on Third Attempt - WSJ
WSJ · 2026-08-06
CytoSorbents plans early-2027 FDA filing for blood-thinner device - Stock Titan
Stock Titan · 2026-08-06
FDA approves Replimune’s melanoma therapy under accelerated pathway
Investing.com · 2026-08-06
FDA approves Replimune melanoma drug previously rejected twice - STAT
STAT · 2026-08-06
Why This Biotech Dealmaker — Tied To Merck, Travere — Charged Higher
Investor's Business Daily · 2026-08-06
Frequently Asked Questions
What is Biotech & FDA?
FDA drug approvals, clinical trial results, and biotech stock-moving news.
Which stocks are in the Biotech & FDA space?
Commonly tracked tickers include LLY, NVO, JNJ, PFE, MRK. Catalayer maintains curated ticker pages with live news at /stocks/ for each.
Why does Biotech & FDA matter for investors?
Biotech & FDA influences market sentiment, sector rotation, and individual stock valuations. Catalayer’s Market Intelligence tier adds AI-powered event classification so you can see which stories are likely to move prices.
How can I monitor Biotech & FDA in real time?
Create a custom keyword monitor on Catalayer with any of these terms: fda, biotech, clinical trial, drug approval, pharma, gene therapy. Free accounts get 1 monitor; Plus ($29/mo) unlocks 5 simultaneous monitors with boolean rules.
Monitor Biotech & FDA News live
Get alerted whenever news matches this topic.